These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 15472001

  • 1. In vitro activity of ertapenem against selected respiratory pathogens.
    Marchese A, Gualco L, Schito AM, Debbia EA, Schito GC.
    J Antimicrob Chemother; 2004 Nov; 54(5):944-51. PubMed ID: 15472001
    [Abstract] [Full Text] [Related]

  • 2. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T, Domingo D, Prieto N, Sánchez S, López-Brea M.
    Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
    Song JH, Ko KS, Lee MY, Park S, Baek JY, Lee JY, Heo ST, Kwon KT, Ryu SY, Oh WS, Peck KR, Lee NY.
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):445-50. PubMed ID: 16949783
    [Abstract] [Full Text] [Related]

  • 4. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S, Ianniello F, Leone S, Esposito S.
    J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 6. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group.
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [Abstract] [Full Text] [Related]

  • 7. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V, Giangrieco M, Durán C, Ojeda A, van Flaskamp R.
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [Abstract] [Full Text] [Related]

  • 8. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J, Fernandes ML, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Acta Med Port; 2001 Dec; 14(5-6):459-68. PubMed ID: 11878155
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of ertapenem: review of recent studies.
    Wexler HM.
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [Abstract] [Full Text] [Related]

  • 12. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan.
    Inoue M, Kohno S, Kaku M, Yamaguchi K, Igari J, Yamanaka K.
    Int J Infect Dis; 2005 Jan; 9(1):27-36. PubMed ID: 15603993
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
    Lee MY, Ko KS, Oh WS, Park S, Lee JY, Baek JY, Suh JY, Peck KR, Lee NY, Song JH.
    Int J Antimicrob Agents; 2006 Jul; 28(1):14-8. PubMed ID: 16777383
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
    Zhanel GG, Derkatch S, Laing N, Noreddin AM, Hoban DJ.
    J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro antibacterial activities of S-013420, a novel bicyclolide, against respiratory tract pathogens.
    Homma T, Fujimura T, Maki H, Yamano Y, Shimada J, Kuwahara S.
    J Antimicrob Chemother; 2010 Jul; 65(7):1433-40. PubMed ID: 20472695
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Resistance patterns of selected respiratory tract pathogens in Poland.
    Skoczyńska A, Kadłubowski M, Waśko I, Fiett J, Hryniewicz W.
    Clin Microbiol Infect; 2007 Apr; 13(4):377-83. PubMed ID: 17359321
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.